Christopher Borges currently serves as the Head of Non-Viral Gene Therapy and Genome Engineering at Sanofi, where leadership is provided to a multidisciplinary team focused on advancing various projects within the Genomics Medicine Unit. Prior to this role, Christopher held the position of Senior Principal Scientist, leading initiatives on genome engineering for rare genetic diseases and cancers. With experience at Editas Medicine as a Senior Scientist specializing in immunogenetics and at Massachusetts General Hospital during graduate studies on T regulatory cells, Christopher has established a robust background in immunology and cell biology. Formal education includes a Ph.D. in Immunology from Harvard University and a Bachelor's degree in Biology with a minor in Mathematics from Emmanuel College, where graduated summa cum laude.
This person is not in the org chart
This person is not in any teams
This person is not in any offices